Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1999 ◽  
Vol 9 (5) ◽  
pp. 461-468 ◽  
Author(s):  
H. A. P. Pols ◽  
D. Felsenberg ◽  
D. A. Hanley ◽  
J. Štepán ◽  
M. Muñoz-Torres ◽  
...  
Keyword(s):  
Bone Density ◽  
Bone Mass ◽  
Fracture Risk ◽  
Randomized Trial ◽  
Postmenopausal Women ◽  
Low Bone Mass

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

Bone ◽  
2008 ◽  
Vol 43 (2) ◽  
pp. 222-229 ◽  
Author(s):  
Paul D. Miller ◽  
Michael A. Bolognese ◽  
E. Michael Lewiecki ◽  
Michael R. McClung ◽  
Beiying Ding ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bone Density ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Phase 2 ◽  
Low Bone Mass ◽  
Phase 2 Clinical Trial

scholarly journals Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

2016 ◽  
Vol 32 (1) ◽  
pp. 181-187 ◽  
Author(s):  
Harry K Genant ◽  
Klaus Engelke ◽  
Michael A Bolognese ◽  
Carlos Mautalen ◽  
Jacques P Brown ◽  
...  
Keyword(s):  
Bone Density ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Low Bone Mass

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Bone ◽  
2019 ◽  
Vol 120 ◽  
pp. 44-49 ◽  
Author(s):  
Elena Tsourdi ◽  
Polyzois Makras ◽  
Tilman D. Rachner ◽  
Stergios Polyzos ◽  
Martina Rauner ◽  
...  
Keyword(s):  
Bone Density ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Previous Treatment ◽  
Low Bone Mass
Sign in / Sign up

Export Citation Format

Share Document